Biogen Inc.BIIBNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$2.52B
↓ 27% below average
Average (9y)
$3.46B
Historical baseline
Range
High:$6.56B
Low:$1.14B
CAGR
-2.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $2.52B | +103.6% |
| 2023 | $1.24B | +8.0% |
| 2022 | $1.14B | -66.2% |
| 2021 | $3.38B | -11.1% |
| 2020 | $3.81B | -42.0% |
| 2019 | $6.56B | +23.8% |
| 2018 | $5.30B | +43.9% |
| 2017 | $3.68B | -4.6% |
| 2016 | $3.86B | +25.6% |
| 2015 | $3.07B | - |